Your browser doesn't support javascript.
loading
Dermatologic inflammatory conditions require high loading and maintenance doses of biologic therapy.
Greif, C; Porter, M L; Kimball, A B.
Affiliation
  • Greif C; Clinical Laboratory for Epidemiology and Applied Research in Skin (CLEARS), Department of Dermatology, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
  • Porter ML; University of Texas Southwestern Medical School, Dallas, Texas, USA.
  • Kimball AB; Clinical Laboratory for Epidemiology and Applied Research in Skin (CLEARS), Department of Dermatology, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
J Eur Acad Dermatol Venereol ; 36(10): e786-e788, 2022 10.
Article in En | MEDLINE | ID: mdl-35617150

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Biological Therapy / Dermatologic Agents Limits: Humans Language: En Journal: J Eur Acad Dermatol Venereol Journal subject: DERMATOLOGIA / DOENCAS SEXUALMENTE TRANSMISSIVEIS Year: 2022 Document type: Article Affiliation country: Estados Unidos

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Biological Therapy / Dermatologic Agents Limits: Humans Language: En Journal: J Eur Acad Dermatol Venereol Journal subject: DERMATOLOGIA / DOENCAS SEXUALMENTE TRANSMISSIVEIS Year: 2022 Document type: Article Affiliation country: Estados Unidos